NOS1 and stroke disorder: Future experimental studies using the selective iNOS and nNOS inhibitors or antiplatelet agents blocking the GPI and GPVI receptors in the management of brain ischemia-reperfusion injury are required to clarify the Janus-faced action of nitric oxide in stroke.